Aytu BioPharma Inc. logo

Aytu BioPharma Inc.

AYTU | NASDAQ
Chart Builder DCF Calculator
$2.27
+$0.15 (+6.82%)
Sep 22, 2026, 2:08 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Jun 29, 2025
FY 2024
Jun 29, 2024
FY 2023
Jun 29, 2023
FY 2022
Jun 29, 2022
FY 2021
Jun 29, 2021
FY 2020
Jun 29, 2020
Cash & Equivalents
30.95M 20.01M 22.99M 19.36M 49.65M 48.08M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a -10.91M n/a
Other Long-Term Assets
1.2M 2.23M 792K 766K 465K 33K
Receivables
31.16M 23.53M 28.94M 21.71M 28.18M 5.63M
Inventory
11.43M 12.14M 12M 10.85M 16.34M 10M
Other Current Assets
n/a 1.12M 868K 633K 1.29M 5.99M
Total Current Assets
79.18M 61.89M 72.83M 59.93M 105.23M 75.42M
Property-Plant & Equipment
1.59M 1.52M 3.87M 6.3M 8.7M 893K
Goodwill & Intangibles
42.2M 52.45M 58.97M 70.63M 151.27M 76.95M
Total Long-Term Assets
45M 56.97M 65.01M 77.69M 160.43M 77.87M
Total Assets
124.18M 118.86M 137.84M 137.62M 265.67M 153.29M
Account Payables
10.6M 10.31M 13.48M 10.99M 19.26M 11.64M
Deferred Revenue
n/a n/a n/a n/a 57.23M 339.34K
Short-Term Debt
10.92M 4.96M 8.74M 3.81M 24.6M 982K
Other Current Liabilities
26.15M 42.35M 41.12M 23.84M 1.47M 8M
Total Current Liabilities
63.06M 62.23M 69.02M 64.44M 109.44M 28.76M
Long-Term Debt
10.9M 10.88M 20.86M 14.2M 2.8M n/a
Other Long-Term Liabilities
30.27M 16.7M 6.4M 14.59M 13.23M 28.79M
Total Long-Term Liabilities
42.15M 28.91M 29.47M 28.87M 18.66M 29.52M
Total Liabilities
105.21M 91.14M 98.48M 93.32M 128.1M 58.28M
Total Debt
22.94M 16.42M 30.43M 18.19M 30.97M 2.01M
Book Value
18.97M 27.72M 39.36M 44.31M 137.57M 95.02M
Book Value Per Share
3.02 5 11.78 30.14 163.77 413.11
Common Stock
1K 1K 1K n/a 3K 1K
Retained Earnings
-333.54M -319.97M -304.13M -287.08M -178.3M -120.01M
Comprehensive Income
n/a n/a n/a 0 n/a n/a
Shareholders Equity
18.97M 27.72M 39.36M 44.31M 137.57M 95.02M
Total Investments
n/a n/a n/a n/a -10.91M n/a

© 2026 bestshares.com. All rights reserved.